CY1124297T1 - Ορολογικη εξεταση για τον ελεγχο της θεραπειας καρκινωματος θετικου σε hpv16 - Google Patents
Ορολογικη εξεταση για τον ελεγχο της θεραπειας καρκινωματος θετικου σε hpv16Info
- Publication number
- CY1124297T1 CY1124297T1 CY20211100609T CY211100609T CY1124297T1 CY 1124297 T1 CY1124297 T1 CY 1124297T1 CY 20211100609 T CY20211100609 T CY 20211100609T CY 211100609 T CY211100609 T CY 211100609T CY 1124297 T1 CY1124297 T1 CY 1124297T1
- Authority
- CY
- Cyprus
- Prior art keywords
- positive carcinoma
- treatment monitoring
- serological test
- treatment
- hpv16 positive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—DNA viruses
- C07K16/084—Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102016124171.7A DE102016124171A1 (de) | 2016-12-13 | 2016-12-13 | Serologischer Test zur Therapiekontrolle von HPV16 positiven Karzinomen |
| PCT/EP2017/082506 WO2018108957A1 (en) | 2016-12-13 | 2017-12-13 | Serologic test for therapy control of hpv16 positive carcinoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124297T1 true CY1124297T1 (el) | 2022-07-22 |
Family
ID=61027644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100609T CY1124297T1 (el) | 2016-12-13 | 2021-07-06 | Ορολογικη εξεταση για τον ελεγχο της θεραπειας καρκινωματος θετικου σε hpv16 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10852303B2 (https=) |
| EP (1) | EP3384292B1 (https=) |
| JP (2) | JP7329244B2 (https=) |
| KR (1) | KR102433541B1 (https=) |
| CN (1) | CN110073219B (https=) |
| BR (1) | BR112019011681A2 (https=) |
| CA (1) | CA3045729A1 (https=) |
| CY (1) | CY1124297T1 (https=) |
| DE (1) | DE102016124171A1 (https=) |
| DK (1) | DK3384292T3 (https=) |
| ES (1) | ES2880489T3 (https=) |
| HR (1) | HRP20211080T1 (https=) |
| HU (1) | HUE054969T2 (https=) |
| LT (1) | LT3384292T (https=) |
| PL (1) | PL3384292T3 (https=) |
| PT (1) | PT3384292T (https=) |
| RS (1) | RS62135B1 (https=) |
| RU (1) | RU2757629C2 (https=) |
| SI (1) | SI3384292T1 (https=) |
| SM (1) | SMT202100421T1 (https=) |
| WO (1) | WO2018108957A1 (https=) |
| ZA (1) | ZA201804516B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102022127779A1 (de) | 2022-10-20 | 2024-04-25 | Ralf Hilfrich | Serologischer Test zum Nachweis von Antikörpern gegen HPV und Testkit |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8062642B1 (en) * | 1993-03-09 | 2011-11-22 | University Of Rochester | Production of papillomavirus capsid protein and virus-like particles |
| US20020193565A1 (en) * | 1998-03-27 | 2002-12-19 | Stanley Margaret Anne | Antigen preparation and use |
| US7067258B2 (en) * | 2002-04-30 | 2006-06-27 | Merck & Co., Inc. | Human papillomavirus multiplexed assay |
| CN101245099A (zh) * | 2007-02-14 | 2008-08-20 | 马润林 | 重组人乳头瘤病毒l1衣壳蛋白的氨基酸序列及其应用 |
| WO2010118424A2 (en) * | 2009-04-10 | 2010-10-14 | The Johns Hopkins University | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| DE102010061028A1 (de) * | 2010-12-03 | 2012-06-06 | Ralf Hilfrich | Schnelltest zum qualitativen und/oder quantitativen Bestimmen von Körperflüssigkeit enthaltenen Antikörpern gegen humane Papillomviren sowie Vorrichtung zum Durchführen des Schnelltests |
| DE102011053741A1 (de) * | 2011-09-19 | 2013-03-21 | Ralf Hilfrich | Verfahren zum Überprüfen der Selbstheilung durch das Immunsystem eines mit humanen Papillomviren infizierten Menschen |
-
2016
- 2016-12-13 DE DE102016124171.7A patent/DE102016124171A1/de not_active Withdrawn
-
2017
- 2017-12-13 PT PT178356028T patent/PT3384292T/pt unknown
- 2017-12-13 DK DK17835602.8T patent/DK3384292T3/da active
- 2017-12-13 US US16/090,159 patent/US10852303B2/en active Active
- 2017-12-13 SM SM20210421T patent/SMT202100421T1/it unknown
- 2017-12-13 BR BR112019011681-8A patent/BR112019011681A2/pt not_active IP Right Cessation
- 2017-12-13 PL PL17835602T patent/PL3384292T3/pl unknown
- 2017-12-13 SI SI201730846T patent/SI3384292T1/sl unknown
- 2017-12-13 WO PCT/EP2017/082506 patent/WO2018108957A1/en not_active Ceased
- 2017-12-13 EP EP17835602.8A patent/EP3384292B1/en active Active
- 2017-12-13 KR KR1020197020463A patent/KR102433541B1/ko active Active
- 2017-12-13 CA CA3045729A patent/CA3045729A1/en active Pending
- 2017-12-13 HR HRP20211080TT patent/HRP20211080T1/hr unknown
- 2017-12-13 ES ES17835602T patent/ES2880489T3/es active Active
- 2017-12-13 JP JP2019532928A patent/JP7329244B2/ja active Active
- 2017-12-13 CN CN201780077269.1A patent/CN110073219B/zh not_active Expired - Fee Related
- 2017-12-13 RU RU2019121882A patent/RU2757629C2/ru active
- 2017-12-13 HU HUE17835602A patent/HUE054969T2/hu unknown
- 2017-12-13 RS RS20210859A patent/RS62135B1/sr unknown
- 2017-12-13 LT LTEP17835602.8T patent/LT3384292T/lt unknown
-
2018
- 2018-07-06 ZA ZA2018/04516A patent/ZA201804516B/en unknown
-
2020
- 2020-09-09 US US17/015,955 patent/US11506667B2/en active Active
-
2021
- 2021-07-06 CY CY20211100609T patent/CY1124297T1/el unknown
-
2022
- 2022-12-15 JP JP2022200001A patent/JP2023029377A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SI3384292T1 (sl) | 2021-08-31 |
| RU2757629C2 (ru) | 2021-10-19 |
| EP3384292B1 (en) | 2021-04-21 |
| KR102433541B1 (ko) | 2022-08-18 |
| LT3384292T (lt) | 2021-07-26 |
| KR20190097155A (ko) | 2019-08-20 |
| BR112019011681A2 (pt) | 2019-10-15 |
| ZA201804516B (en) | 2019-04-24 |
| RS62135B1 (sr) | 2021-08-31 |
| RU2019121882A3 (https=) | 2021-04-09 |
| RU2019121882A (ru) | 2021-01-15 |
| SMT202100421T1 (it) | 2021-09-14 |
| JP2020501162A (ja) | 2020-01-16 |
| JP7329244B2 (ja) | 2023-08-18 |
| US20190113516A1 (en) | 2019-04-18 |
| US11506667B2 (en) | 2022-11-22 |
| ES2880489T3 (es) | 2021-11-24 |
| CN110073219B (zh) | 2023-09-05 |
| CN110073219A (zh) | 2019-07-30 |
| US20200408768A1 (en) | 2020-12-31 |
| EP3384292A1 (en) | 2018-10-10 |
| JP2023029377A (ja) | 2023-03-03 |
| PL3384292T3 (pl) | 2021-10-25 |
| DK3384292T3 (da) | 2021-06-28 |
| WO2018108957A1 (en) | 2018-06-21 |
| HRP20211080T1 (hr) | 2021-10-01 |
| HUE054969T2 (hu) | 2021-10-28 |
| CA3045729A1 (en) | 2018-06-21 |
| US10852303B2 (en) | 2020-12-01 |
| DE102016124171A1 (de) | 2018-06-14 |
| PT3384292T (pt) | 2021-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2019000006A (es) | Anticuerpos nuevos que se unen específicamente a los epítopos del virus del zika y usos de los mismos | |
| JP1754773S (ja) | サンプル採取器具 | |
| EA201791148A1 (ru) | Способ определения абсолютных количеств hla-рестриктированных раковых пептидов, образовавшихся в результате естественного процессинга | |
| MX374652B (es) | Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco. | |
| MX382486B (es) | Métodos para diagnosticar enfermedades infecciosas usando medio de adsorción. | |
| EA201690213A1 (ru) | Композиции и способ лечения связанных с комплементом состояний | |
| EA201690796A1 (ru) | Способ диагностики первичного гиперальдостеронизма | |
| BR112018008799A2 (pt) | método de prognóstico | |
| BR112014026440A8 (pt) | análises, métodos e aparelhos para avaliação de disrupção de rna. | |
| MX2017006075A (es) | Biomarcadores para la progresion de enfermedades en melanoma. | |
| CY1119873T1 (el) | Βελτιωμενα διαγνωστικα εμβολιου | |
| EA202090587A1 (ru) | Способ получения сплит-вакцины с на гриппа | |
| CY1124297T1 (el) | Ορολογικη εξεταση για τον ελεγχο της θεραπειας καρκινωματος θετικου σε hpv16 | |
| WO2015189591A3 (en) | Method and arrays for use in diagnosing early breast cancer | |
| MX2016017136A (es) | Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2). | |
| MX384485B (es) | Deteccion temprana de preeclampsia. | |
| EP3972645C0 (en) | METHODS FOR IDENTIFYING HIV PATIENTS SUSCEPTIBLE TO THERAPY WITH ANTIBODIES DIRECTED AGAINST GLYCAN V3 OF GP120 | |
| BR112016002709A2 (pt) | queratinas como biomarcadores para câncer cervical e sobrevivência | |
| PL3801213T3 (pl) | Sposób do wykrywania ilości tlenku azotu no wytworzonego przez badany obiekt, i urządzenie do wdrożenia wspomnianego sposobu | |
| UY36431A (es) | Anticuerpos monoclonales específicos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por hmpv | |
| WO2015077541A3 (en) | Mycobacterium biomarkers and methods | |
| EP4065733C0 (en) | METHOD AND KIT FOR THE DETECTION OF STRAINS OF E. EXTRA-INTESTINAL COLI PATHOGENS TO POULTRY | |
| RU2013151981A (ru) | Способ определения типа психики индивидуума | |
| UA131673U (uk) | Спосіб ушивання анодерми після фісуректомії | |
| UA91322U (uk) | Проведення серологічної реакції проби росту з кров'ю на фільтрувальному папері |